CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
Lawrence D Mayer, Paul Tardi, Arthur C LouieJazz Pharmaceuticals, Inc., Palo Alto, CA, USAAbstract: Combination regimens are a standard of care for many cancers. However, components of such regimens are typically first developed individually and subsequently combined using strategies to minimize tox...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2019-05-01
|
| coleção: | International Journal of Nanomedicine |
| Assuntos: | |
| Acesso em linha: | https://www.dovepress.com/cpx-351-a-nanoscale-liposomal-co-formulation-of-daunorubicin-and-cytar-peer-reviewed-article-IJN |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|